Search - tctmd.com

Displaying 721 - 740 of 746

Sort: Relevancy | Date

News Daily News

Liraglutide Leaps Over FDA Safety Hurdle, With Cardiovascular Mortality Reduction to Boot: LEADER

Michael O'Riordan

June 14, 2016

News Daily News

Estudio LEADER: Liraglutide se Salta la Valla de Seguridad de la FDA al Confirmarse un Descenso de la Mortalidad Cardiovascular

Michael O'Riordan

June 14, 2016

News Daily News

La Colaboración de Ensayistas para el Tratamiento del Colesterol Vuelve a Analizar los Episodios Adversos secundarios a las Estatinas

Michael O'Riordan

June 13, 2016

News Daily News

Adverse Events Linked with Statins Get a Second Look From Cholesterol Treatment Trialists’ Collaboration

Michael O'Riordan

June 13, 2016

News Daily News

Broader, Primary Prevention Role for High-Sensitivity Troponin Tests Suggested by ARIC Analysis

Shelley Wood

June 10, 2016

News Daily News

Air Pollution Joins List of Leading Causes of Stroke Worldwide

Todd Neale

June 10, 2016

News Daily News

Detection and Treatment of Severe FH Depends on LDL Levels, Not Genes, Says Expert Panel

Michael O'Riordan

June 09, 2016

News Conference News EAS 2016

Nutrition and Physical Activity: The ‘Low-Hanging Fruit’ for Cardiologists Programmed to Prescribe Pills

Yael L. Maxwell

June 07, 2016

News Industry News

New Haven Pharmaceuticals Presents Positive Data That Shows DURLAZA™ is Well Tolerated and Delivers Sustained 24-hour Antiplatelet Control

March 01, 2016

News Daily News

ITALIC Published: No Benefit to Long-Term DAPT After Stenting

Yael L. Maxwell

March 10, 2015

News Daily News

Registro del CORONOR: Warfarin a Largo Plazo + Agente Antiplaquetario Aumenta las Hemorragias en Pacientes con EAC Estable

L.A. McKeown

October 03, 2014

News Daily News

CORONOR Registry: Long-term Warfarin Plus Antiplatelet Increases Bleeding in Stable CAD Patients

L.A. McKeown

October 03, 2014

News Daily News

La Alta Reactividad a la Aspirina Justo Antes de la PCI se asocia a Peores Resultados

September 02, 2014

News Daily News

High Reactivity on Aspirin Just Before PCI Linked to Worse Outcomes

September 02, 2014

News Conference News TCT 2013

Triple Antiplatelet Therapy with Cilostazol Increases Tachycardia, Arrhythmias

November 04, 2013

News Conference News ACC 2013

Aspirin Alone Just as Good as Dual Antiplatelet Therapy Beyond 12 Months

Jason Kahn

March 11, 2013

News Daily News

Risk Factor Control Linked to Better Outcomes After Peripheral Intervention

Caitlin E. Cox

December 16, 2012

News Daily News

Meta-analysis Questions Benefit of Longer Dual Antiplatelet Therapy Post-PCI

November 28, 2012

News Daily News

Meta-análisis cuestiona beneficio de la terapia antiplaquetaria doble extendida después la PCI

November 28, 2012

News Daily News

Studies Suggest Less Stringent Dual Antiplatelet Use After DES

September 20, 2012

Advertisement

Liraglutide Leaps Over FDA Safety Hurdle, With Cardiovascular Mortality Reduction to Boot: LEADER

Estudio LEADER: Liraglutide se Salta la Valla de Seguridad de la FDA al Confirmarse un Descenso de la Mortalidad Cardiovascular

La Colaboración de Ensayistas para el Tratamiento del Colesterol Vuelve a Analizar los Episodios Adversos secundarios a las Estatinas

Adverse Events Linked with Statins Get a Second Look From Cholesterol Treatment Trialists’ Collaboration

Broader, Primary Prevention Role for High-Sensitivity Troponin Tests Suggested by ARIC Analysis

Air Pollution Joins List of Leading Causes of Stroke Worldwide

Detection and Treatment of Severe FH Depends on LDL Levels, Not Genes, Says Expert Panel

Nutrition and Physical Activity: The ‘Low-Hanging Fruit’ for Cardiologists Programmed to Prescribe Pills

New Haven Pharmaceuticals Presents Positive Data That Shows DURLAZA™ is Well Tolerated and Delivers Sustained 24-hour Antiplatelet Control

ITALIC Published: No Benefit to Long-Term DAPT After Stenting

Registro del CORONOR: Warfarin a Largo Plazo + Agente Antiplaquetario Aumenta las Hemorragias en Pacientes con EAC Estable

CORONOR Registry: Long-term Warfarin Plus Antiplatelet Increases Bleeding in Stable CAD Patients

La Alta Reactividad a la Aspirina Justo Antes de la PCI se asocia a Peores Resultados

High Reactivity on Aspirin Just Before PCI Linked to Worse Outcomes

Triple Antiplatelet Therapy with Cilostazol Increases Tachycardia, Arrhythmias

Aspirin Alone Just as Good as Dual Antiplatelet Therapy Beyond 12 Months

Risk Factor Control Linked to Better Outcomes After Peripheral Intervention

Meta-analysis Questions Benefit of Longer Dual Antiplatelet Therapy Post-PCI

Meta-análisis cuestiona beneficio de la terapia antiplaquetaria doble extendida después la PCI

Studies Suggest Less Stringent Dual Antiplatelet Use After DES

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content